Checchi Capital Advisers’s Teva Pharmaceuticals TEVA Stock Holding History

Checchi Capital Advisers’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-6,203	Closed	-$285K	–	402
2016 Q3	$285K	Buy	6,203 +1,772	+40%	+$92.5K	0.03%	268
2016 Q2	$223K	Sell	4,431 -2,694	-38%	-$143K	0.03%	312
2016 Q1	$381K	Buy	7,125 +2,638	+59%	+$155K	0.08%	193
2015 Q4	$295K	Buy	4,487 +470	+12%	+$29K	0.07%	242
2015 Q3	$227K	Sell	4,017 -1,004	-20%	-$65.1K	0.06%	291
2015 Q2	$297K	Buy	+5,021	New	+$310K	0.08%	227
2014 Q4	–	Sell	-4,533	Closed	-$244K	–	343
2014 Q3	$244K	Hold	4,533	–	–	0.1%	213
2014 Q2	$238K	Buy	+4,533	New	+$232K	0.11%	194

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Checchi Capital Advisers's TEVA Position: Q4 2016 in Review

Checchi Capital Advisers sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 6,203 shares — an estimated $285K sold.

Checchi Capital Advisers first reported a position in TEVA in Q2 2014 and held it in 8 quarters. The position peaked at $381K in Q1 2016. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Checchi Capital Advisers reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Checchi Capital Advisers sold 6,203 Teva Pharmaceuticals shares in Q4 2016, an estimated $285K.
Checchi Capital Advisers first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 8 quarters.
Checchi Capital Advisers's Teva Pharmaceuticals position peaked at $381K in Q1 2016.
739 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Checchi Capital Advisers's 13F filing for Q4 2016, filed 25 Jan 2017.